Hypericum Depression Trial Study Group, Davidson JR, Gadde KM, Fairbank JA, Krishnan KRR, Califf RM, Binanay C, Parker CB, Pugh N, Hartwell TD, Vitiello B, Ritz L, Severe J, Cole JO, de Battista C, Doraiswamy PM, Feighner JP, Keck P, Kelsey J, Lin KM, Londborg PD, Nemeroff CB, Schatzberg AF, Sheehan DV, Srivastava RK, Taylor L, Trivedi MH, Weisler RH
V.SheikhM
Potential issues may include: Underdosed products Poor peptide quality Inconsistent administration Protocols that are too short Concentrations that are too low for the severity of the condition In many situations, the issue may not be that peptides do not work, but rather that the body is not receiving adequate and consistent support for long enough
Excessively rapid detoxification symptoms may occur if toxic mobilization outpaces elimination capacity, particularly in individuals with significant heavy metal burdens or compromised detoxification capacity
Continued daily monitoring throughout use reveals any trends